IP Library Granted Patent US 9,150,914
Granted Patent B2
US 9,150,914 · App. 13/852,711 · Granted Oct 6, 2015

Methods and compositions for amplification and sequencing of difficult DNA templates

Inventors: Shihong Li (Berkeley Heights, NJ); Narisra Jongkam (Highland Park, NJ); Shifang Zhang (New York, NY); Conrad Leung (Edison, NJ)
Assignee: Genewiz Inc., Suzhou
C12Q1/6869C12Q2525/117C12Q2531/125
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,150,914
App. No.
13/852,711
Granted
Oct 6, 2015
Kind
B2
Abstract

This disclosure provides methods and compositions for amplification and sequencing of DNA templates, comprising at least two of: 2′-deoxyinosine-5′ triphosphate, 5-propynyl-2′-deoxycytidine-5′-triphosphate, and 8-oxo-2′-deoxyguanosine-5′-triphosphate. Incorporation of these promoting nucleotides into amplification and sequencing reactions improves the amplification and sequencing of difficult-to-sequence DNA regions such as a GC rich regions or GT rich regions; repetitive sequences, including dinucleotide, trinucleotide, direct, inverted, Alu, poly A or poly T repeats; and hairpin or other secondary structures.

Claims (17)

1. A method for amplifying a DNA template, comprising:

a. providing a DNA template and an exonuclease-resistant random hexamer primer;

b. denaturing said DNA template;

c. annealing said DNA template with said primer; and

d. incubating said template and said primer with a nucleotide composition comprising at least two of: 2′-deoxyinosine-5′ triphosphate, 5-propynyl-2′-deoxycytidine-5′-triphosphate, and 8-oxo-2′-deoxyguanosine-5′-triphosphate, for a time sufficient for said template to be amplified.

2. The method of claim 1 , wherein the DNA template is a circular DNA template.

3. The method of claim 2 , wherein said circular DNA template comprises at least one of the following: a GC rich or GT rich sequence, a homopolymer repetitive sequence; or a hairpin secondary structure.

4. The method of claim 1 , wherein said circular DNA template is provided in step (a) in an amount of 1 pg to 500 ng.

5. The method of claim 1 , wherein said template and said primer are incubated in step (d) at 28-32° C. for 2-18 hours.

6. The method of claim 1 wherein in step (d) said template and said primer are incubated with a composition comprising:

a mixture of nucleotides dATP, dCTP, dGTP and dTTP,

DNA polymerase with strand displacement activity,

a buffer,

a magnesium salt, and

one or more ammonia sulfate salts,

for a time sufficient for said template to be amplified.

7. The method of claim 1 , wherein the nucleotide composition of step (d) comprises all three of 2′-deoxyinosine-5′ triphosphate, 5-propynyl-2′-deoxycytidine-5′-triphosphate, and 8-oxo-2′-deoxyguanosine-5′-triphosphate.

Assignments (10)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 048030/0733 Recorded Nov 4, 2025
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: GENEWIZ, LLC
Reel/Frame 073445/0362 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 049610/0562 Recorded Nov 4, 2025
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: GENEWIZ, LLC
Reel/Frame 073445/0357 →
SECURITY INTEREST Recorded Jun 27, 2019
From: GENEWIZ, LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 049610/0562 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR'S NAME PREVIOUSLY RECORDED AT REEL: 048030 FRAME: 0733. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Jan 17, 2019
From: GENEWIZ, LLC
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 048089/0692 →
SECURITY INTEREST Recorded Jan 16, 2019
From: GENEWIZ, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 048030/0733 →
RELEASE OF SECURITY INTEREST Recorded Jun 30, 2017
From: CAPITAL ONE, NATIONAL ASSOCISTION
To: GENEWIZ, LLC
Reel/Frame 042876/0772 →
SECURITY INTEREST Recorded Nov 20, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT
Reel/Frame 037100/0352 →
SECURITY INTEREST Recorded Feb 5, 2015
From: GENEWIZ, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 034895/0266 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2013
From: GENEWIZ INC
To: GENEWIZ INC., SUZHOU
Reel/Frame 030691/0865 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2013
From: LI, SHIHONG; JONGKAM, NARISRA; ZHANG, SHIFANG; LEUNG, CONRAD
To: GENEWIZ INC.
Reel/Frame 030612/0781 →
Continuity (2)
Provisional Application 61617245 · Mar 29, 2012
Related Publication 20130316352A1 · Nov 28, 2013